Abstract is: A ganglioside is a molecule composed of a glycosphingolipid (ceramide and oligosaccharide) with one or more sialic acids (e.g. N-acetylneuraminic acid, NANA) linked on the sugar chain. NeuNAc, an acetylated derivative of the carbohydrate sialic acid, makes the head groups of gangliosides anionic at pH 7, which distinguishes them from globosides. The name ganglioside was first applied by the German scientist Ernst Klenk in 1942 to lipids newly isolated from ganglion cells of the brain. More than 60 gangliosides are known, which differ from each other mainly in the position and number of NANA residues. It is a component of the cell plasma membrane that modulates cell signal transduction events, and appears to concentrate in lipid rafts. Recently, gangliosides have been found to be highly important molecules in immunology. Natural and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.
| structural class of chemical entities | Q47154513 |
| acidic glycosphingolipid | Q66589614 |
| P268 | Bibliothèque nationale de France ID | 12046937j |
| P508 | BNCF Thesaurus ID | 3946 |
| P5019 | Brockhaus Enzyklopädie online ID | ganglioside-biochemie |
| P683 | ChEBI ID | 28892 |
| P6706 | De Agostini ID | ganglioside |
| P4746 | Elhuyar ZTH ID | 132129 |
| P1417 | Encyclopædia Britannica Online ID | science/ganglioside |
| P1402 | Foundational Model of Anatomy ID | 82816 |
| P646 | Freebase ID | /m/04mjqr |
| P12385 | Gran Enciclopèdia Catalana ID | gangliosid |
| P1296 | Gran Enciclopèdia Catalana ID (former scheme) | 0111179 |
| P2924 | Great Russian Encyclopedia Online ID (old version) | 2343795 |
| P3827 | JSTOR topic ID (archived) | gangliosides |
| P665 | KEGG ID | C01808 |
| P244 | Library of Congress authority ID | sh85053023 |
| P2063 | LIPID MAPS ID | LMSP0601 |
| P486 | MeSH descriptor ID | D005732 |
| P672 | MeSH tree code | D09.400.410.420.025.475 |
| D10.390.470.025.475 | ||
| D10.570.877.360.025.475 | ||
| P6366 | Microsoft Academic ID | 2777331542 |
| P2004 | NALT ID | 42318 |
| P8189 | National Library of Israel J9U ID | 987007557915605171 |
| P950 | National Library of Spain ID | XX527630 |
| P3222 | NE.se ID | gangliosid |
| P10283 | OpenAlex ID | C2777331542 |
| P5076 | Römpp online ID | RD-07-00168 |
| P2892 | UMLS CUI | C0017082 |
| P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
| P361 | part of | ganglioside catabolic process | Q14905000 |
| ganglioside biosynthetic process | Q21108259 | ||
| ganglioside binding | Q21109823 | ||
| ganglioside metabolic process | Q21109832 | ||
| ganglioside biosynthetic process via lactosylceramide | Q22276409 |
| Q106030762 | GD1a ganglioside(C18) |
| Q4864602 | GD2 |
| Q10860794 | GM1 (stereochemistry not completely specified) |
| Q63105760 | GM1(12:0) |
| Q5513693 | GM2 (ganglioside) |
| Q116909504 | GT1b |
| Q63104327 | GalNAc-GM1b |
| Q72480015 | Ganglioside GIII |
| Q38131965 | alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide |
| Q27162543 | alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/16:0) |
| Q27157972 | alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/20:0) |
| Q27157975 | alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/22:0) |
| Q27157977 | alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:0) |
| Q27157978 | alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:1(15Z)) |
| Q27157988 | alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/18:0) |
| Q27157989 | alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/22:0) |
| Q27162581 | alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:0) |
| Q27157983 | alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/16:0) |
| Q27157984 | alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/18:0) |
| Q27157985 | alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/20:0) |
| Q27157986 | alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/22:0) |
| Q27157987 | alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:0) |
| Q27128572 | alpha-Neu5Ac-(2->3)-beta-Gal-(1->3)-beta-GalNAc-(1->4)-beta-Gal-(1->4)-beta-Glc-(1<->1')-N-stearoylsphingosine |
| Q27162413 | alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)-beta-Gal-(1->3)-beta-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer(d18:1/18:0) |
| Q27162419 | alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer(d18:1/18:0) |
| Q27157979 | beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/16:0) |
| Q27157980 | beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:0) |
| Q27157982 | beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:1(15Z)) |
| Q27159690 | beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->8)-alpha-Neup5Ac-(2->3)]-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer(d18:1/18:0) |
| Q27162418 | beta-Gal-(1->3)-beta-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer(d18:1/18:0) |
| Q27157966 | beta-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-Gal-(1->4)-beta-Glc-(1->1')-Cer(d18:1/16:0) |
| Q27157990 | beta-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-Gal-(1->4)-beta-Glc-(1->1')-Cer(d18:1/18:0) |
| Q75909571 | ganglioside GD1b |
| Q106030757 | ganglioside GM2 (16:0) |
| Q106030751 | ganglioside GM2 (20:0) |
| Q106030754 | ganglioside GM2 (24:0) |
| Q27148157 | ganglioside X1 |
| Q27148156 | ganglioside X2 |
| Q67867747 | A simple method to detect contaminating peptides and amino acids in large-scale ganglioside preparations |
| Q48741689 | Biosynthesis of glycolipids in myelin deficient mutants: Brain glycosyl transferases in Jimpy and Quaking mice |
| Q39205117 | Gangliosides and phospholipids from frog and duck retina |
| Q46143680 | Promotion of neuronal survival in vitro by thermal proteins and poly(dicar☐ylic) amino acids |
| Q69416595 | Regulation of myelinogenesis |
| Q48710405 | Sub-synaptosomal localization of brain particulate neuraminidase |
| Q48775532 | -Ketosidic linkage of the neuraminidase-resistent neuraminic acid in brain gangliosides |
| Q76942603 | 8. MEASUREMENT OF LIPIDS IN THE BRAIN TISSUE. II. GLYCOLIPIDS |
| Q78279690 | A CONTRIBUTION TO THE BIOCHEMISTRY OF TAY-SACHS DISEASE |
| Q51281682 | A CONTROLLED STUDY OF ENZYMIC ACTIVITIES IN THREE HUMAN DISORDERS OF GLYCOLIPID METABOLISM |
| Q76851844 | A SENSITIVE METHOD FOR QUANTITATIVE MICRODETERMINATION OF LIPIDS |
| Q39615746 | A case of GM-Gangliosidosis (atypical form of the AB variant) |
| Q67522935 | A case of GM1 gangliosidosis |
| Q38358971 | A ganglioside spin label: Ganglioside head group interactions |
| Q40127935 | A model for ganglioside behaviour in cell membranes |
| Q48395709 | A nuclear magnetic resonance study of the interaction of serotonin with gangliosides |
| Q64041127 | A perilous path: the inborn errors of sphingolipid metabolism |
| Q67315638 | A simple and novel method for tritium labeling of gangliosides and other sphingolipids |
| Q41739577 | Action of Arthrobacter ureafaciens sialidase on sialoglycolipid substrates. Mode of action and highly specific recognition of the oligosaccharide moiety of ganglioside GM1 |
| Q39995425 | Action of Clostridium perfringens neuraminidase on gangliosides GM1 and GM2 above and below the critical micelle concentration of substrate |
| Q39217632 | Action of endogenous neuraminidase on sialo compounds in the developing chick retina |
| Q48259247 | Analysis of hexosaminitol-containing disaccharide alditols from rat brain glycoproteins and gangliosides as O-trimethylsilyl derivatives by gas chromatography mass spectrometry |
| Q72609067 | Analytical separation of nonlipid water soluble substances and gangliosides from other lipids by dextran gel column chromatography |
| Q67655154 | Binding of colchiceine to isolated gangliosides and ganglioside-containing membranes (author's transl) |
| Q38357719 | Binding of d-Tubocurarine by Gangliosides |
| Q67812020 | Binding of ganglioside by the chains of tetanus toxin |
| Q76488405 | Biochemistry of Tay-Sacks disease |
| Q39811055 | Biotransducers of Membrane-Mediated Information |
| Q48418571 | Brain neuraminidases and gangliosides |
| Q38359202 | C20-sphingosine as a determining factor in aggregation of gangliosides |
| Q35458099 | CELL MEMBRANE CONSTITUENTS CONCERNED WITH TRANSPORT MECHANISMS |
| Q36186095 | CHEMICAL AND ULTRASTRUCTURAL COMPARISON OF SYNTHETIC AND PATHOLOGIC MEMBRANE SYSTEM |
| Q51253300 | CHEMICAL STUDIES ON ALZHEIMER'S DISEASE |
| Q51284598 | CHROMATOGRAPHIC STUDIES OF NORMAL AND TAY-SACHS GANGLIOSIDES (PEPTIDE-STRANDIN) |
| Q51283844 | CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES* |
| Q39944576 | Case of late infantile form of gangliosidosis G-M1 |
| Q47846451 | Cerebral organoids derived from Sandhoff disease induced pluripotent stem cells exhibit impaired neurodifferentiation. |
| Q51242818 | Changes in sphingosine and fatty acid components of the gangliosides in developing rat and human brain |
| Q39655481 | Characterization of a blood group I-active ganglioside. Structural requirements for I and i specificities |
| Q66850601 | Characterization of two gangliosides from human leukemic polymorphonuclear leukocytes |
| Q41924918 | Chemical Structures of Three Fucogangliosides Isolated from Nervous Tissue of Mini‐Pig |
| Q48435074 | Chemical structure of monosialoganglioside Gmib biosynthesized in vitro |
| Q51266796 | Chemical studies on brain gangliosides in normal and pathological states |
| Q39993693 | Chemistry of gangliosides |
| Q35569302 | Clinical and enzymatic variations in G M1 generalized gangliosidosis |
| Q72878960 | Clustering of gangliosides in phospholipid bilayers |
| Q38358013 | Comparison of the Interaction of Mono- and Oligovalent Ligands with Cholera Toxin. Demonstration of Aggregate Formation at Low Ligand Concentrations |
| Q28330168 | Critical micelle concentrations of gangliosides |
| Q48247886 | Demonstration of 9-O-acetyl-N-acetylneuraminic acid in brain gangliosides from various vertebrates including man |
| Q72660260 | Design of a cholera erythrocytic enterotoxic ganglioside indicator for detecting specific immunoglobulins |
| Q51242813 | Determination of brain gangliosides by determination of ganglioside stearic acid |
| Q43856947 | Determination of glycosphingolipid structures by mass spectrometry |
| Q44049276 | Dissociation of cholera toxin functional regions after interaction with vesicles containing ganglioside GM1 |
| Q64054875 | Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson's Disease |
| Q51253290 | ELECTRON MICROSCOPY OF TWO CEREBRAL BIOPSIES IN GARGOYLISM |
| Q48122476 | Effect of Development on the Gangliosides of Rabbit Brain |
| Q71560665 | Electron microscopic studies on feline GI-gangliosidosis with similarities to Tay-Sachs disease |
| Q51115123 | Enzymatic Action of Sialidase of Vibrio cholerae on Brain Gangliosides above and below the Critical Micelle Concentration |
| Q76487514 | Epileptogenic action of substances that interact with gangliosides. In vivo release of lysosomal enzymes as a disease mechanism |
| Q51246924 | Evidence for a second trisialo ganglioside |
| Q39933097 | Evidence for the Complex Nature of the Ganglioside Receptor for Cholera Toxin |
| Q34093724 | Evidence for the presence of two separate protein activators for the enzymic hydrolysis of GM1 and GM2 gangliosides |
| Q28271943 | Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins |
| Q51269408 | FLUOROMETRIC ASSAY OF SIALIC ACID IN BRAIN GANGLIOSIDES |
| Q51273914 | FRACTIONATION OF BRAIN MACROMOLECULES. II. ISOLATION OF PROTEIN-LINKED SIALOMUCOPOLYSACCHARIDES FROM SUBCELLULAR, PARTICULATE FRACTIONS FROM RAT BRAIN |
| Q76867143 | FURTHER GANGLIOSIDES FROM THE HUMAN BRAIN |
| Q48425094 | Fluidity of natural membranes and phosphatidylserine and ganglioside dispersions. Effect of local anesthetics, cholesterol and protein |
| Q43503404 | Formation of ganglioside internal esters by treatment with trichloroacetic acid-phosphotungstic acid reagent |
| Q51253791 | GENERALIZED GANGLIOSIDOSIS: ANOTHER INBORN ERROR OF GANGLIOSIDE METABOLISM? |
| Q77000559 | GLYCOLIPIDS |
| Q39768163 | Ganglioside GM 2 thesaurismosis (Sandhoff's disease) |
| Q51296581 | Ganglioside in Maturing Rat Brain |
| Q67389550 | Ganglioside orientation in vesicular bilayer membranes |
| Q71407320 | Ganglioside series. III. Synthesis of 4-O-(2-acetamido-2-deoxy-.beta.-D-galactopyranosyl)-D-galactopyranose |
| Q39783348 | Ganglioside structures and distribution: Are they localized at the nerve ending? |
| Q71188498 | Gangliosides |
| Q72612835 | Gangliosides and Other Glycolipids of Human Placenta |
| Q33596395 | Gangliosides and autoimmune neuropathies: classification and clinical aspects of autoimmune neuropathies |
| Q39984381 | Gangliosides of Hepatoma 27, Normal and Regenerating Rat Liver |
| Q48892153 | Gangliosides of extraneuronal tissue |
| Q66979161 | Gangliosides of human erythrocytes. A novel ganglioside with a unique N-acetylneuraminosyl-(2 .fwdarw. 3)-N-acetylgalactosamine structure |
| Q48344112 | Gangliosides of human kidney |
| Q39918706 | Gangliosides of the bovine neurohypophysis |
| Q40832803 | Gangliosides of the nervous system: chemical and immunological characterization (author's transl) |
| Q43870899 | Gangliosides of the optic pathway: biosynthesis and biodegradation studied in vivo |
| Q61807665 | Glial Sulfatides and Neuronal Complex Gangliosides Are Functionally Interdependent in Maintaining Myelinating Axon Integrity |
| Q51252667 | Glycolyl-neuraminic Acid in Ox Brain Gangliosides |
| Q40100816 | Glycosphingolipids in membrane architecture |
| Q35190647 | Guillain-Barré syndrome after exogenous gangliosides in Italy |
| Q36174702 | Guillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey |
| Q76734110 | HISTOCHEMICAL DEMONSTRATION OF SULFURIC ACID ESTERS WITH TRYPAFLAVIN |
| Q51293375 | Histological Distribution of Brain Gangliosides: Lysosomes as Glycolipoprotein Granules |
| Q38361647 | Hydrolysis of GM1-ganglioside by human liver β-galactosidase isoenzymes |
| Q72844114 | Hydrolysis of di- and trisialo gangliosides in micellar and liposomal dispersion by bacterial neuraminidases |
| Q76824071 | IDENTIFICATION BY GAS-CHROMATOGRAPHY OF THE GLYCOLIC ACID CONTENT OF SIALIC ACIDS OF VARIOUS ORIGINS |
| Q78552696 | INFLUENZA VIRUS INHIBITORS |
| Q78397295 | INTERACTION OF MACROCATIONS AND MACROANIONS WITH MITOCHONDRIA |
| Q78519364 | ISOLATION AND PURIFICATION OF GANGLIOSIDES AND DETERMINATION OF THEIR RADIOACTIVITY FOLLOWING ADMINISTRATION OF C-14 |
| Q39931954 | Identification of the internal acetal 5-acetamido-2,7-anhydro-3,5-dideoxy-D-glycero-D-galacto-nonulopyranose |
| Q66907972 | In Vivo Distribution of Vesicles Loaded with Radiopharmaceuticals: A Comparison of Different Routes of Administration |
| Q39276852 | In-vitro-studies on the influence of cations, neurotransmitters and tubocurarine on calcium-ganglioside-interactions |
| Q39592832 | Interaction between lectin and liposomes containing gangliosides [proceedings] |
| Q43860037 | Interaction between vesicles containing gangliosides and limulin (Limulus polyphemus lectin). Fluorescence polarization of 1,6-diphenyl-1,3,5-hexatriene |
| Q35083242 | Interaction of cholera toxin and membrane GM1 ganglioside of small intestine |
| Q38358347 | Interaction of choleragen with the oligosaccharide of ganglioside GM1: evidence for multiple oligosaccharide Binding sites |
| Q46408519 | Interaction of human brain neuroaminidase with tritium-labelled gangliosides |
| Q47921886 | Interaction of protamine with gangliosides & its use in the removal of endogenous gangliosides from sheep brain neuraminidase |
| Q48712120 | Interaction of triiodide anion with gangliosides in aqueous iodine |
| Q48720724 | Ionic properties of beef brain gangliosides |
| Q43601492 | Is there a decrease in Guillain-Barré syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy. |
| Q67404712 | Isolation and characterization of GD3 ganglioside having a novel disialosyl residue from rabbit thymus |
| Q66961600 | Isolation and characterization of two isomers of brain tetrasialogangliosides |
| Q43626245 | Isolation and partial characterization of human kidney gangliosides |
| Q41459561 | Isolation and partial characterization of the neutral glycosphingolipids and gangliosides of the human heart |
| Q72605906 | Isolation of Cholera Toxin by Affinity Chromatography on Porous Silica Beads with Covalently Coupled Ganglioside GM1 |
| Q76859016 | LIPID COMPONENTS OF GANGLIOSIDES |
| Q51276442 | LIPID DISTRIBUTION IN SUBCELLULAR FRACTIONS OF THE RAT BRAIN |
| Q41421636 | Labeling of natural substrates for the radiochemical assay of enzymes involved in lipid storage diseases: a general procedure for tritiation of gangliosides |
| Q48343999 | Lectin-receptor interactions in liposomes. II. Interaction of wheat germ agglutinin with phosphatidylcholine liposomes containing incorporated monosialoganglioside |
| Q70945705 | Lipid insertion of cholera toxin after binding to GM1-containing liposomes |
| Q35487598 | METABOLISM AND FUNCTION OF PHOSPHOLIPIDS AND SPHINGOLIPIDS |
| Q51255012 | MICROASSAY OF BIOCHEMICAL STRUCTURAL COMPONENTS IN NERVOUS TISSUES. I. EXTRACTION AND PARTITION OF LIPIDS AND ASSAY OF NUCLEIC ACIDS |
| Q44769571 | Magnetic microspheres prepared by redox polymerization used in a cell separation based on gangliosides |
| Q40750328 | Methylation analysis determination of acylneuraminic acid residue type 2→8 glycosidic linkage Application to GT1bganglioside and colominic acid |
| Q67448672 | Methylation analysis of the major gangliosides of the human alimentary mucosa |
| Q48729310 | Mixtures of gangliosides and phosphatidylcholine in aqueous dispersions |
| Q69170478 | Molecular Mechanism of Tay–Sachs Disease |
| Q41733629 | Monomer-Micelle Transition of the Ganglioside GM1 and the Hydrolysis by Clostridium perfringens Neuraminidase |
| Q76923722 | NEUROCHEMICAL AND NEUROPATHOLOGICAL STUDY OF A CASE OF NIEMANN-PICK DISEASE IN A YOUNG INFANT |
| Q40037914 | Neuraminic acid-specific modification and tritium labelling of gangliosides |
| Q43416564 | Neuraminidase gangliosides interactions |
| Q51118042 | Neuronal GM 1 Gangliosidosis in a Siamese Cat with β-Galactosidase Deficiency |
| Q43731306 | Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies |
| Q51286779 | OCCURRENCE OF 2-HYDROXY FATTY ACIDS IN ANIMAL TISSUES |
| Q76779483 | ON A GLUCOSAMINE-CONTAINING GANGLIOSIDE |
| Q78418068 | ON GANGLIOSIDES IN BRAIN TUMORS |
| Q78260879 | ON RETINAL GANGLIOSIDES. 3. SPLITTING OF N-ACETYL-AND N-GLYCOLYL-NEURAMINIC ACIDS FROM GANGLIOSIDES OF THE BOVINE RETINA |
| Q78538290 | ON RETINAL GANGLIOSIDES. II. PRELIMINARY STUDIES |
| Q76989020 | ON THE PRESENCE OF A GANGLIOSIDE IN BOVINE SUBMAXILLARY GLAND |
| Q72479281 | Observation of a case of GM1 gangliosidosis |
| Q76486596 | On a 2d hexose-containing ganglioside from human brain |
| Q79073174 | On enzymatic splitting of gangliosides in the bovine retina |
| Q41634765 | On the composition and structure of individual gangliosides from the brain of elasmobranches |
| Q69920254 | On the discovery and chemistry of neuraminic acid and gangliosides |
| Q78969513 | On the gangliosides of the brain |
| Q79057491 | On the problem of the quantitative determination of gangliosides in the brain |
| Q42958286 | PHYSICOCHEMICAL PROPERTIES OF OX-BRAIN GANGLIOSIDES |
| Q76824243 | PRELIMINARY STUDIES ON THE PRESENCE OF GANGLIOSIDES IN THE BRAIN AND ON THE PRODUCTS OF ENZYMATIC SCISSION OF GANGLIOSIDES |
| Q78954061 | Pharmacologically active lipidsoluble acids in brain extracts: isolation of lysophosphatidic acid and ganglioside |
| Q34254492 | Phase behavior of ganglioside-lecithin mixtures. Relation to dispersion of gangliosides in membranes |
| Q45071851 | Preparation of radioactive Tay-Sachs ganglioside labeled in the sialic acid moiety |
| Q66943875 | Preparation of radiolabeled GM2 and GA2 gangliosides |
| Q43871471 | Proceedings: Neuraminidase-sensitive gangliosides: possible tissue receptors for thermostable direct hemolysin of Vibrio parahaemolyticus |
| Q28633750 | Purification and Characterization of an Activator Protein for the Degradation of Glycolipids GM2and GA2by Hexosaminidase A |
| Q33191928 | RECENT DATA ON THE HISTOCHEMISTRY OF PATHOLOGICAL OCULAR CHANGES IN TAY-SACHS DISEASE |
| Q78499220 | RETINAL GANGLIOSIDES. I. QUALITATIVE AND QUANTITATIVE STUDIES |
| Q34422883 | SEROTONIN RECEPTORS. IV. SPECIFIC DEFICIENCY OF RECEPTORS IN GALACTOSE POISONING AND ITS POSSIBLE RELATIONSHIP TO THE IDIOCY OF GALACTOSEMIA |
| Q51253083 | STRUCTURE COMPARISON OF THE MAJOR MONOSIALOGANGLIOSIDES FROM BRAINS OF NORMAL HUMAN, GARGOYLISM, AND LATE INFANTILE SYSTEMIC LIPIDOSIS. I |
| Q51281619 | STUDIES IN GLOBOID (KRABBE) LEUKODYSTROPHY. II. CONTROLLED THIN-LAYER CHROMATOGRAPHIC STUDIES OF GLOBOID BODY FRACTIONS IN SEVEN PATIENTS |
| Q51269750 | STUDIES OF BRAIN LYSOSOMES. I. SUBCELLULAR DISTRIBUTION OF FIVE ACID HYDROLASES, SUCCINATE DEHYDROGENASE AND GANGLIOSIDES IN RAT BRAIN |
| Q51267418 | STUDIES ON BRAIN GANGLIOSIDES. 3. EVIDENCE FOR THE LOCATION OF GANGLIOSIDES SPECIFICALLY IN NEURONES |
| Q51272755 | STUDIES ON BRAIN GANGLIOSIDES. I. THE ISOLATION AND COMPOSITION OF A TRISIALOGANGLIOSIDE |
| Q51272729 | STUDIES ON BRAIN GANGLIOSIDES. II. ANALYSIS OF HUMAN BRAIN GANGLIOSIDE FRACTIONS OBTAINED BY PREPARATIVE THIN-LAYER CHROMATOGRAPHY |
| Q51265879 | STUDIES ON BRAIN GANGLIOSIDES. IV. THE EFFECT OF HYPERCAPNIA ON GANGLIOSIDES IN VIVO |
| Q51252750 | STUDIES ON BRAIN TISSUE OF TAY-SACHS' DISEASE. IV. PARTITIONING OF GANGLIOSIDES INTO A CHLOROFORM-RICH PHASE |
| Q76997057 | STUDIES ON TISSUE THROMBOPLASTIN. 1. PURIFICATION, CHEMICAL CHARACTERISTICS AND SEPARATION INTO PROTEIN AND LIPID COMPONENTS |
| Q51270852 | STUDY ON GANGLIOSIDE METABOLISM—I INCORPORATION OF d‐[U‐14C]GLUCOSE INTO INDIVIDUAL GANGLIOSIDES* |
| Q48743475 | Sandhoff's disease (GM 2 gangliosidosis type 2): clinical, chemical, and enzyme studies in five patients |
| Q51286339 | Separation of human brain gangliosides |
| Q59094940 | Serotonin Receptors: V, Selective Destruction by Neuraminidase Plus EDTA and Reactivation with Tissue Lipids |
| Q34455492 | Serotonin receptors, VII. Activities of various pure gangliosides as the receptors |
| Q51250737 | Some effects of physiological cations on the behaviour of gangliosides in a chloroform-methanol-water biphasic system |
| Q67851135 | Specific interaction between concanavalin A and glycolipids incorporated into planar bilayer membranes |
| Q66954933 | Specific interaction between follitropin and GM1 ganglioside incorporated into lipid membranes |
| Q71045920 | Specific tritium labeling of gangliosides at the 3-position of sphingosines |
| Q67706480 | Structural specificity of gangliosides |
| Q67769799 | Structure and specificity of gangliosides |
| Q39417732 | Structure of tetanus toxin. II. Toxin binding to ganglioside |
| Q66926169 | Structure of the major gangliosides from bovine thyroid |
| Q39926792 | Structures of gangliosides from bovine adrenal medulla |
| Q51290013 | Studies in Tay-Sachs diseases. III. Biochemistry. B. Catabolism of gangliosides and related compounds |
| Q51290018 | Studies on Tay-Sachs disease. III. Biochemistry. A. Analytic and metabolic aspects |
| Q68928205 | Studies on the interaction between gangliosides, protein and divalent cations |
| Q52701391 | Surface Properties of Membrane Systems: Interaction of Ketamine with Monomolecular Films of Gangliosides and Mitochondrial Lipids |
| Q42006491 | Surface behaviour of gangliosides and related glycosphingolipids |
| Q76504564 | THE ACTION OF NEURAMINIDASE FROM CLOSTRIDIUM PERFRINGENS ON GANGLIOSIDES |
| Q76508680 | THE CONSTITUTION OF GANGLIOSIDES G-II, G-III AND G-IV |
| Q51265833 | THE DISTRIBUTION OF LIPIDS IN THE HUMAN NERVOUS SYSTEM. I. ANALYTICAL PROCEDURE. LIPIDS OF FOETAL AND NEWBORN BRAIN |
| Q51281039 | THE GLYCOLIPIDS OF THE BRAIN OF TAY-SACHS' DISEASE.--THE CHEMICAL STRUCTURES OF A GLOBOSIDE AND MAIN GANGLIOSIDE |
| Q78279693 | THE ISOLATION AND IDENTIFICATION OF SIX GANGLIOSIDES AND THE ACTION OF GANGLIOSIDASE OF PURIFIED GANGLIOSIDES |
| Q51267413 | THE PRODUCTION OF ANTISERA TO GANGLIOSIDES FROM HUMAN NERVOUS TISSUE |
| Q78281417 | THE QUANTITATIVE DETERMINATION OF GANGLIOSIDES AND THEIR NEURAMINIC ACID-FREE DERIVATIVES IN INFANTILE, JUVENILE AND FORMS OF AMAUROTIC IDIOCY AND AN UNUSUAL LATE INFANTILE BIOCHEMICAL FORM |
| Q37592957 | Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy. |
| Q51292473 | Tetanus toxin activity and ganglioside content of rat brain |
| Q39983957 | The Evidence that Ganglioside, a Metal, and Chemical Energy are Involved in the Serotonin Household of Synaptic Vesicles from Brain |
| Q40055699 | The binding of thyrotropin to liposomes containing gangliosides |
| Q40030806 | The chemistry of gangliosides: A review |
| Q39688579 | The complexing ability of gangliosides for Ca2, I. Influence of mono- and divalent cations and of acetylcholin (author's transl) |
| Q48905542 | The effect of calcium on ganglioside solubility |
| Q51236921 | The lipid composition of purified bovine brain myelin |
| Q51250426 | The pattern of mammalian brain gangliosides. II. Evaluation of the extraction procedures, postmortem changes and the effect of formalin preservation |
| Q36450863 | Thermotropic Behavior and Electronmicroscopic Structures of Mixtures of Gangliosides and Dipalmitoylphosphatidylcholine1 |
| Q51253287 | ULTRASTRUCTURAL AND BIOCHEMICAL OBSERVATIONS ON A CASE OF SYSTEMIC LATE INFANTILE LIPIDOSIS AND ITS RELATIONSHIP TO TAY-SACHS DISEASE AND GARGOYLISM |
| Q23320717 | Zika virus and neurologic autoimmunity: the putative role of gangliosides |
| Category:Gangliosides | wikimedia | |
| Arabic (ar / Q13955) | غانغليوزيد | wikipedia |
| Catalan (ca / Q7026) | Gangliòsid | wikipedia |
| Gangliosidy | wikipedia | |
| Ganglioside | wikipedia | |
| Ganglioside | wikipedia | |
| Gangliósido | wikipedia | |
| Basque language (eu / Q8752) | Gangliosido | wikipedia |
| Persian (fa / Q9168) | گانگلیوزید | wikipedia |
| Gangliosidit | wikipedia | |
| Ganglioside | wikipedia | |
| gl | Gangliósido | wikipedia |
| Gangliosidi | wikipedia | |
| ガングリオシド | wikipedia | |
| Ганглиозидтер | wikipedia | |
| mk | Ганглиозид | wikipedia |
| Norwegian, Nynorsk (nn / Q25164) | Gangliosid | wikipedia |
| Gangliosídio | wikipedia | |
| Gangliozidă | wikipedia | |
| Ганглиозиды | wikipedia | |
| Serbo-Croatian (sh / Q9301) | Gangliozid | wikipedia |
| Gangliozid | wikipedia | |
| Gangliozid | wikipedia | |
| Ганглиозидҳо | wikipedia | |
| Гангліозиди | wikipedia | |
| yue | 神經節苷脂 | wikipedia |
| 神经节苷脂 | wikipedia |
Search more.